SSA is one of the largest
federal government programs in existence with an annual IT budget in excess of 1 billion dollars, over 1,300 field offices, and over 103,000 workstations.
The example of Easy Being Green's success led to much stronger State and
Federal government programs in energy efficiency, including for low income households.
Not exact matches
The company was
in the midst of negotiating a new round of financing and awaiting a cheque from the
federal government's Scientific Research and Experimental Development
program — both of which eventually came through.
Omada Health has accomplished a rare feat
in the crowded world of digital health hopefuls: it's backed up lofty claims with actual results, helping the company score
federal government reimbursements for its high - tech diabetes prevention
program.
The next swing he felt was
in 1980, when Prime Minister Pierre Trudeau's Liberal
government introduced the National Energy
Program, seeking more
federal control over the energy industry.
These
programs provide free one - on - one mentoring and low - cost training opportunities for their clients
in locations around the country, using a combination of
federal funds, state and local
government contributions, and private sector resources.
The Conference Board notes that the
federal government has placed great emphasis
in improving Canada's innovation performance for years, most directly
in the 2012 budget's revamping of how $ 3.5 billion is doled out to firms under the Scientific Research and Experimental Development
program.
The five - year
program, launched by the
federal government in early January, proposes to make over 90 percent of the total U.S. offshore acreage available to oil and gas drilling.
The ORPP was billed Thursday as a mandatory plan that will be modelled on the CPP and could be absorbed into the national
program if the
federal government agreed to a CPP enhancement
in the future.
These are the SBA's flagship 7 (a) loan
program, which gives 5,000 banks participating
in the
program access to loan guarantees by the
federal government.
«Any time you roll out a big
government program like this, confusion is inevitable,» said Lois Greisman, an associate director
in the Bureau of Consumer Protection at the
Federal Trade Commission.
While some observers see the plan as yet another way
in which the provinces are pressuring the
federal government to expand CPP, Ontario's opposition Progressive Conservatives have already condemned the
program as a «job - killing payroll tax.»
Under the
program, the
federal government pays the lion's share
in the early years but the state contribution gradually increases.
The
federal government limits tax - deductible contributions to retirement plans; for most plans, such as 401 (k)
programs, the maximum amount you can receive
in contributions
in 2016 is $ 53,000 if you're under the age of 50, and $ 59,000 if you're eligible to make «catch - up» contributions.
In 2010, as the Federal Reserve continued its quantitative easing program, Buffett sent the government a «thank you note» (in the form of an op - ed) for its actions, rather than its paralysis or politicking, after the crisi
In 2010, as the
Federal Reserve continued its quantitative easing
program, Buffett sent the
government a «thank you note» (
in the form of an op - ed) for its actions, rather than its paralysis or politicking, after the crisi
in the form of an op - ed) for its actions, rather than its paralysis or politicking, after the crisis.
In addition, many government agencies at the state and federal levels have created set - aside programs that specifically help women - owned businesses in the bidding proces
In addition, many
government agencies at the state and
federal levels have created set - aside
programs that specifically help women - owned businesses
in the bidding proces
in the bidding process.
Some banks weren't able to lend for a while because of TARP,» Geshwiler says, referring to the Troubled Asset Relief
Program, the federal government's program for bailing out banks hit hard in the financial
Program, the
federal government's
program for bailing out banks hit hard in the financial
program for bailing out banks hit hard
in the financial crisis.
In the late 1990s the SBA introduced a new Business Development Mentor - Protege
Program meant to help improve the fortunes of 8 (a) participants seeking
federal government contracts.
He applied via the
Federal Immigrant Investor
Program, a scheme granting permanent residency
in return for a tax - free loan to the
government.
The
Federal Communications Commission's Lifeline
program paid at least $ 1.2 million to duplicate or deceased recipients and more than one - third of participants out of 3.5 million reviewed appeared not to be eligible, the
Government Accountability Office said
in a report released on Thursday.
Statistics Canada reports that spending on home repairs and maintenance increased 22 %
in 2009 over the previous year, «likely due to the
federal government home renovation tax credit
program.»
My plan would make significant investments
in reentry
programs for those formally incarcerated and I will ban the box
in the
federal government.
The Canadian Media Guild (which also represents unionized workers at The Canadian Press) worries the new money from the
federal government wasn't a reinvestment
in the CBC so much as spending on companies producing CBC
programming.
Back
in 1986, the
federal government introduced the Immigrant Investor
Program, which offered permanent residency
in exchange for a three - year investment of $ 150,000.
Oracle (orcl) also said
in April that it would donate $ 200 million over the next 18 months to a
federal government program for computer science education.
A report released by the Labor Department
in 2016, called the «Workforce Investment Act Gold Standard Evaluation,» concluded that the
federal government's primary job - training
programs don't really work.
A growing trend
in some areas is for
federal or local
government - financed
programs to provide whatever capital gets layered
in with bank money.
And they book
in big savings from
program cuts that are still working their way through the
federal government.
The ad blocker would be part of the Google Chrome Browser, which is the most popular browser
in the US according to a January report from the
federal government's Digital Analytics
Program.
The
federal government announced initial changes
in April, scrapping an aspect of the
program that allowed employers to pay foreign workers as much as 15 per cent less than the average wage for a job.
Trump signed the Reducing Poverty
in America by Promoting Opportunity and Economic Mobility executive order on Tuesday, directing
federal agencies to expand work requirements for those who receive benefits from
government assistance
programs such as Medicaid, SNAP, and public housing.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and
government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven by
federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other
government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«The
federal government should do everything within its authority to empower individuals by providing opportunities for work, including by investing
in federal programs that are effective at moving people into the workforce and out of poverty,» the order read, according to CNN.
Individuals who participate
in an income - driven repayment
program, work at a non-profit organization, or work for the
federal government may qualify to have their loan balances forgiven after a set number of years on on - time, consecutive payment.
The
federal government also offers student loan forgiveness to borrowers who elect to participate
in an income - driven repayment
program.
For its part, the
federal government, from the earliest census
in 1790 to the creation of New Deal social welfare
programs, has long relied on aggregate as well as individual data to distribute resources and administer benefits.
Direct
program expenses were up $ 1.0 billion (5.5 %), primarily due to the timing of payments as well as an increase
in federal government employee pension and other future benefit liabilities, reflecting the impact of lower interest rates.
On February 3, 2011, the C.D. Howe Institute released its 2011Shadow Budget [1] entitled A Faster Track to Fiscal Balance, arguing that
federal government should undertake aggressive actions to restrain the growth
in program expenses
in order to achieve a fiscal surpluses one year earlier than forecast
in the October 2010 Update [2].
We can hold our own
in attracting information - technology talent given computer science
programs at major universities and
federal government cybersecurity operations.
Premiums under the Affordable Care Act will increase from 12 percent to 32 percent next year unless the
federal government steps
in, according to a study that examines the fallout from President Donald Trump's attempts to chip away at the
program.
In the 2006 Budget, the government promised to reduce the deficit by $ 3 billion per year; to reduce the federal debt - to - GDP ratio to 25 per cent by 2012 - 13; to eliminate the total government sector debt (which includes the federal, provincial and local governments as well as the Canada and Quebec pension plans) by 2021; and finally, to keep the growth in program expenses below the rate of growth in nominal GD
In the 2006 Budget, the
government promised to reduce the deficit by $ 3 billion per year; to reduce the
federal debt - to - GDP ratio to 25 per cent by 2012 - 13; to eliminate the total
government sector debt (which includes the
federal, provincial and local
governments as well as the Canada and Quebec pension plans) by 2021; and finally, to keep the growth
in program expenses below the rate of growth in nominal GD
in program expenses below the rate of growth
in nominal GD
in nominal GDP.
Instead,
programs like the
federal government's National Flood Insurance
Program, which helps homeowners pay for damage from floods, ends up encouraging people to rebuild
in areas that are likely to get flooded again.
There is also no doubt that without these tax cuts the
government would have been
in a much better fiscal position to deal with the 2009 - 2010 recession; that any resulting deficit, would have been eliminated much earlier than 2015 - 16, and without the need for draconian cuts
in federal programs and services.
Evan Solomon: The
government of Alberta, they point to these statistics: the oil sands creates $ 307 billion
in tax revenue, $ 187 billion for the
federal government, 23 % of employment is from oil sands, 7 % of employment
in Canada from the oil sands and
in Ontario alone, 7 %, they say, of employment comes from the oil sands and they say royalties of $ 1.9 billion fund
programs across the country.
Instead, the
federal government has introduced changes to
programs (Canada Health Transfer, elderly benefits, etc.)
in the Budget Implementation Bill, without providing a proper context for the need for change.
The
federal government also could see significant cost - savings, as Medicare and Medicaid (which is a joint state -
federal program) both pitch
in to cover non-emergency medical transportation, costing the feds around $ 3 billion a year.
The
Federal Communications Commission
in April proposed barring the use of funds from a
government program to purchase equipment or services from companies that pose a security threat to U.S. communications networks.
Off - budget:
Federal government expenditures on certain
programs, agencies, and
government sponsored enterprises that are accounted for separately
in the budget to prevent spending changes or avoid a conflict of interest.
The Saskatchewan Rental Housing Supplement designed to help low income families and people with disabilities pay their rent will be replaced by a
program co-developed with the
federal government slated for implementation
in 2020.
It envisioned a dramatically smaller role for the
federal government, a role that was permanently
in question through the process of ongoing
program review.